Dementia Incidence Varied by Anticancer Drugs and Molecular Targeted Therapy in a Population-based Cohort Study

Overview

Journal Sci Rep

Specialty Science

Date 2024 Jul 30

PMID 39080315

Authors

Eun Hye Lee

Danbee Kang

Jin Lee

Sang Won Seo

Chi-Hun Kim

Juhee Cho

Affiliations

Soon will be listed here.

Abstract

Anticancer drugs may affect the incidence of dementia by modulating the common pathophysiology between cancer and dementia. However, there is a paucity of research that focused on anticancer drugs with different mechanisms of action and their associations with subtypes of dementia. Therefore, we aimed to investigate the incidence of dementia according to various groups of anticancer drugs. From the Korea National Health Insurance Service database, our retrospective population-based cohort study enrolled 116,506 cancer patients aged 65 years and older who received anticancer drugs between January 1, 2008 and December 31, 2018. The hazard ratio was determined using Cox proportional hazards regression models, comparing each group of anticancer drugs to all other anticancer drugs, after adjusting for covariates. Antimetabolites (HR = 0.91; 95% CI 0.84-0.97) and molecular targeted therapies (HR = 0.60; 95% CI 0.49-0.74) were associated with a decreased incidence of dementia of the Alzheimer type (DAT), but not with vascular dementia. Among molecular targeted therapies, epidermal growth factor receptor inhibitors (HR = 0.60; 95% CI 0.46-0.79) and multikinase inhibitors (HR = 0.49; 95% CI 0.27-0.89) were associated with a low incidence of DAT only. Our findings highlight the potential for targeted repurposing of anticancer drugs to prevent dementia.

References

Chen Y, Hsu C, Shiao Y, Wang H, Lo Y, Lin A . Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation. Sci Rep. 2019; 9(1):2516. PMC: 6385176. DOI: 10.1038/s41598-019-38676-7. View

Echeverria V, Burgess S, Gamble-George J, Zeitlin R, Lin X, Cao C . Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience. 2009; 162(4):1220-31. DOI: 10.1016/j.neuroscience.2009.05.019. View

Choi H, Jeong Y, Kim J, Hoe H . EGFR is a potential dual molecular target for cancer and Alzheimer's disease. Front Pharmacol. 2023; 14:1238639. PMC: 10433764. DOI: 10.3389/fphar.2023.1238639. View

Sun M, Wang Y, Sundquist J, Sundquist K, Ji J . The Association Between Cancer and Dementia: A National Cohort Study in Sweden. Front Oncol. 2020; 10:73. PMC: 7010720. DOI: 10.3389/fonc.2020.00073. View

Kang J, Shin D, Han K, Park S, Lee W, Yoo J . Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea. Curr Probl Cancer. 2020; 44(6):100578. DOI: 10.1016/j.currproblcancer.2020.100578. View

Wang L, Chiang H, Wu W, Liang B, Xie Z, Yao X . Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss. Proc Natl Acad Sci U S A. 2012; 109(41):16743-8. PMC: 3478595. DOI: 10.1073/pnas.1208011109. View

Chung S, Lin H, Tsai M, Kao L, Huang C, Chen K . Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer. Andrology. 2016; 4(3):481-5. DOI: 10.1111/andr.12187. View

Driver J, Beiser A, Au R, Kreger B, Lee Splansky G, Kurth T . Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ. 2012; 344:e1442. PMC: 3647385. DOI: 10.1136/bmj.e1442. View

Shim M, Bang W, Oh C, Lee Y, Jeon S, Ahn H . Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study. PLoS One. 2020; 15(12):e0244660. PMC: 7773184. DOI: 10.1371/journal.pone.0244660. View

10.

Garwood C, Pooler A, Atherton J, Hanger D, Noble W . Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011; 2:e167. PMC: 3168992. DOI: 10.1038/cddis.2011.50. View

11.

Dubois B, Lopez-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S . Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial. Alzheimers Res Ther. 2023; 15(1):39. PMC: 9972756. DOI: 10.1186/s13195-023-01169-x. View

12.

Kozminski P, Halik P, Chesori R, Gniazdowska E . Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers. Int J Mol Sci. 2020; 21(10). PMC: 7279024. DOI: 10.3390/ijms21103483. View

13.

Lee J, Lee J, Park S, Shin S, Kim K . Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2016; 46(2):e15. DOI: 10.1093/ije/dyv319. View

14.

OBrien J, Thomas A . Vascular dementia. Lancet. 2015; 386(10004):1698-706. DOI: 10.1016/S0140-6736(15)00463-8. View

15.

Javidnia M, Hebron M, Xin Y, Kinney N, Moussa C . Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy. J Alzheimers Dis. 2017; 60(2):461-481. PMC: 5757517. DOI: 10.3233/JAD-170429. View

16.

Mansour H, Fawzy H, El-Khatib A, Khattab M . Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer's disease. Neural Regen Res. 2022; 17(9):1913-1918. PMC: 8848623. DOI: 10.4103/1673-5374.332132. View

17.

Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C . Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology. 2013; 81(4):322-8. DOI: 10.1212/WNL.0b013e31829c5ec1. View

18.

Du X, Xia R, Hardy D . Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort. Am J Clin Oncol. 2009; 33(6):533-43. DOI: 10.1097/COC.0b013e3181b9cf1b. View

19.

Ancidoni A, Bacigalupo I, Remoli G, Lacorte E, Piscopo P, Sarti G . Anticancer drugs repurposed for Alzheimer's disease: a systematic review. Alzheimers Res Ther. 2021; 13(1):96. PMC: 8101105. DOI: 10.1186/s13195-021-00831-6. View

20.

Roe C, Fitzpatrick A, Xiong C, Sieh W, Kuller L, Miller J . Cancer linked to Alzheimer disease but not vascular dementia. Neurology. 2009; 74(2):106-12. PMC: 2809029. DOI: 10.1212/WNL.0b013e3181c91873. View